Advertisement

Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px

News > All

Total search results: 6736 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg. 2022-03-21
Nagi Bioscience S.A.. (3/21/22). "Press Release: The SERI-funded EIC Accelerator Program Grants Nagi Bioscience with €2.5 Million to Accelerate Development and Commercial Scale-up of Their Unique ‘Organism-on-Chip’ Product". Lausanne. 2022-03-21
Bavarian Nordic A/S. (3/21/22). "Press Release: Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21
BigOmics Analytics S.A.. (3/17/22). "Press Release: BigOmics Closes Pre-Series A with Additional Investment from Eppendorf". Lugano. 2022-03-17
Bruker Corporation. (3/16/22). "Press Release: Bruker Appoints Philip Ma to Its Board of Directors". Billerica, MA. 2022-03-16
Immunic, Inc.. (3/16/22). "Press Release: Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial Officer". New York, NY. 2022-03-16
Gilde Healthcare Partners. (3/16/22). "Press Release: Gilde Healthcare Raises more than €500 Million for Private Equity Investments in European Healthcare Companies". Utrecht. 2022-03-16
InfanDx AG. (3/15/22). "Press Release: Neonatal Diagnostics Company InfanDx AG Closes Oversubscribed Second Tranche of Series A". Cologne & Boston, MA. 2022-03-15
Adrenomed AG. (3/15/22). "Press Release: Adrenomed Supervisory Board Appoints Dr. Richard Jones as CEO". Hennigsdorf. 2022-03-15
Temedica GmbH. (3/15/22). "Press Release: Temedica Announces Cooperation with Bristol Myers Squibb for the Development of a Digital Companion for Psoriasis Patients". Munich. 2022-03-15
Bruker Corporation. (3/15/22). "Press Release: Bruker Leads $46 Million New Financing Round for PrognomiQ to Advance Development of Next-Generation Multi-omics Liquid Biopsy Products for Cancer". San Mateo, CA. 2022-03-15
Ginkgo Bioworks Inc.. (3/14/22). "Press Release: Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-high-throughput Screening Platform". Boston, MA & Basel. 2022-03-14
Ayoxxa Biosystems GmbH. (3/14/22). "Press Release: Ayoxxa Receives Fresh Capital for Commercial Growth in Europe, US and Asia Led by Prosnav Capital". Cologne. 2022-03-14
Forbion Capital Partners. (3/14/22). "Press Release: Forbion Strengthens Its Team with the Appointments of Mathias Vinther and Vanessa Carle". Naarden. 2022-03-14
MedXCell S.A.. (3/11/22). "Press Release: MedXCell SA Is Proud to Annonce the Arrival of Andrew Galzaka and John D. McMannis as New Members of the Board and Pierre J.Magistretti as New Scientific Advisor". Montreux. 2022-03-11
MorphoSys AG. (3/10/22). "Press Release (Ad hoc): MorphoSys AG Reports Non-cash Impairment Charge of approx. € 231 Million on Goodwill after Consolidation of Research and Discovery Functions, Corresponding Increase of Group Operating Expenses in 2021". P 2022-03-10
Scenic Biotech B.V.. (3/10/22). "Press Release: Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases". Amsterdam. 2022-03-10
Heidelberg Pharma AG. (3/10/22). "Press Release: Heidelberg Pharma Receives Milestone Payment from Partner Magenta for Dosing the First Patient with MGTA-117". Ladenburg. 2022-03-10
Vaximm AG. (3/8/22). "Press Release: NEC OncoImmunity Acquires Vaximm’s Neoantigen Vaccine Development Assets". Oslo, Tokyo, Basel & Mannheim. 2022-03-08
BioNTech SE. (3/8/22). "Press Release: BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo (cemiplimab) Combination in NSCLC". Mainz. 2022-03-08
Enzymicals AG. (3/8/22). "Press Release: Enzymicals AG Board of Supervisors Appoints New Management with Dr. Erik de Vries as CEO". Greifswald. 2022-03-08
Solvias AG. (3/8/22). "Press Release: Solvias Appoints Archie Cullen Chief Executive Officer". Kaiseraugst. 2022-03-08
Singleron Biotechnologies. (3/7/22). "Press Release: Singleron Acquires Proteona". Nanjing, Suzhou, Cologne & Singapore. 2022-03-07
Enamine Ltd.. (3/7/22). "Press Release: Open Letter from Enamine Founder and CEO Dr. Andrey Tolmachov". 2022-03-07
LenioBio GmbH. (3/7/22). "Press Release: LenioBio Closes Its Series-A Extension Round and Strengthens Its Board of Directors". Düsseldorf. 2022-03-07
Kurma Partners. (3/7/22). "Press Release: Kurma Partners Targets €250 Million for its First Growth Opportunities Fund". Paris. 2022-03-07
InxMed Co., Ltd.. (3/4/22). "Press Release: InxMed Raised $50 Million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers". Nanjing. 2022-03-04
ArrePath. (3/3/22). "Press Release: ArrePath Announces $20 Million Seed Financing to Advance its Machine Learning-based Platform for Discovery of Novel Anti-infectives Addressing Antimicrobial Resistance". Princeton, NJ. 2022-03-03
Epsilogen Ltd.. (3/2/22). "Press Release: Epsilogen Announces Completion of Oversubscribed £30.75 Million ($41.20 Million) Series B Financing". London. 2022-03-02
Ampersand Capital Partners. (3/1/22). "Press Release: BioEcho Life Sciences Receives Growth Equity Investment from Ampersand Capital Partners". Cologne. 2022-03-01
CureVac N.V.. (3/1/22). "Press Release: CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer". Tübingen & Boston, MA. 2022-03-01
ECBF Management GmbH. (3/1/22). "Press Release: €34M to End Chick Culling. Impact Fund ECBF Invests In AgTech In Ovo". Luxembourg. 2022-03-01
EQT AB. (3/1/22). "Press Release: EQT Closes Acquisition of LSP and Introduces EQT Life Sciences". 2022-03-01
Heidelberg Pharma AG. (2/28/22). "Press Release: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment". Ladenburg. 2022-02-28
Editas Medicine, Inc.. (2/28/22). "Press Release: Editas Medicine Announces Favorable Decision from U.S. Patent and Trademark Office in CRISPR Patent Interference". Cambridge, MA. 2022-02-28
Evolva Holding S.A.. (2/28/22). "Press Release: Carsten Däweritz Remains CFO of Evolva". Reinach. 2022-02-28
Medigene AG. (2/25/22). "Press Release: Dr. Selwyn Ho Appointed New CEO of Medigene". Lisbon. 2022-02-25
Celeris Therapeutics GmbH. (2/24/22). "Press Release: CelerisTx Appoints Pharmaceuticals Industry Leader Peter Ho, M.D., Ph.D., to the Board of Directors". Menlo Park, CA. 2022-02-24
ECBF Management GmbH. (2/23/22). "Press Release: Growth Capital for Sustainable Transformation to a Bio-based Circular Economy. EU-initiated Impact Fund Oversubscribed with € 300 million". Luxembourg. 2022-02-23
Poseida Therapeutics, Inc.. (2/22/22). "Press Release: Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy". San Diego, CA. 2022-02-22
FZI Forschungszentrum Informatik. (2/21/22). "Press Release: Busy Bees in Search of Data. OCELI Project Makes Causes of Bee Mortality Measurable". Karlsruhe. 2022-02-21
Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain. 2022-02-21
BioNTech SE. (2/21/22). "Press Release: BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer". Mainz & Martinsried. 2022-02-21
Vibalogics GmbH. (2/18/22). "Press Release: Vibalogics Acquired by Top Global CDMO Recipharm AB". 2022-02-18
Jeito Capital. (2/17/22). "Press Release: Jeito Capital Announces the Appointments of Dr Andreas Wallnöfer as Partner Investor and Isabelle Meyrier as Head of Legal". Paris. 2022-02-17
Heidelberg Pharma AG. (2/17/22). "Press Release: Heidelberg Pharma AG Secures Financing Commitment From its Main Shareholder dievini (ad hoc)". Ladenburg. 2022-02-17
SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona. 2022-02-16
Climedo Health GmbH. (2/16/22). "Press Release: Climedo Closes €5 Million Seed Financing Round". Munich. 2022-02-16
ITM Isotope Technologies Munich SE. (2/16/22). "Press Release: ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma". Garching & Hong Kong. 2022-02-16
Centauri Therapeutics Ltd.. (2/16/22). "Press Release: Centauri Therapeutics Closes £24 million GBP Series A Investment Round". London. 2022-02-16
XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. 2022-02-16
SHS Gesellschaft für Beteiligungsmanagement mbH. (2/15/22). "Press Release: SHS Sells Leading Enzyme Engineering Company c-LEcta GmbH to Kerry Group". Tübingen. 2022-02-15
Marinomed Biotech AG. (2/15/22). "Press Release: Marinomed Receives €6m with Final Tranche of Financing Agreement with EIB to Invest in Proprietary R&D Pipeline". Korneuburg. 2022-02-15
Kerry Group plc. (2/15/22). "Press Release: Kerry Announces Significant Strategic Biotechnology Acquisitions". 2022-02-15
NMD Pharma A/S. (2/15/22). "Press Release: NMD Pharma Raises €35 Million in a New Financing". Aarhus. 2022-02-15
c-LEcta GmbH. (2/15/22). "Press Release: c-LEcta Announces that it Has Reached Agreement to Be Acquired by Kerry Group". 2022-02-15
IMIdomics, Inc.. (2/15/22). "Press Release: IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE". San Rafael, CA & Barcelona. 2022-02-15
ProBioGen AG. (2/11/22). "Press Release: ProBioGen Signs a Commercial License Agreement with AstraZeneca Providing their GlymaxX® Technology". Berlin. 2022-02-11
Green Elephant Biotech GmbH. (2/11/22). "Press Release: Pre-seed Funding Round for Green Elephant Biotech. BMH Invests in Developer of Sustainable Cell Cultivation Systems". Wiesbaden & Gießen. 2022-02-11
Celeris Therapeutics GmbH. (2/10/22). "Press Release: CelerisTx Announces $4.4m Financing to Advance Pipeline of Novel Proximity Inducing Compound". Menlo Park, CA. 2022-02-10
Haya Therapeutics S.A.. (2/9/22). "Press Release: Haya Therapeutics Establishes U.S. Location. Haya Closes US$5M Seed Extension". Lausanne & San Diego, CA. 2022-02-09
Lindis Blood Care GmbH. (2/9/22). "Press Release: Lindis Blood Care Successfully Closes Follow-on Financing Round". Hennigsdorf. 2022-02-09
AiCuris Anti-infective Cures AG. (2/9/22). "Press Release: AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-acting RNA-based Therapy against BK Virus". Wuppertal & Leiden. 2022-02-09
Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA. 2022-02-09
ECBF Management GmbH. (2/9/22). "Press Release: Insect Scale-up Protix Raises 50 Million for Expansion and Development from International Investors". Wuppertal & Leiden. 2022-02-09
BRAIN Biotech AG. (2/8/22). "Press Release: BRAIN Biotech and Formo. Strategic Partnership of European Biotech Experts for the Production of Animal-free Milk Protein". Zwingenberg. 2022-02-08
Inova Software S.A.S.. (2/8/22). "Press Release: Inova Acquires In-Part, Matchmaking Platform for Academia-Industry Collaboration". Lyon. 2022-02-08
Evolva Holding S.A.. (2/8/22). "Press Release: Evolva Appoints Christian Wichert as New CEO to Boost Growth Strategy and Enter Its Next Phase of Development and Commercialization". Reinach. 2022-02-08
ECBF Management GmbH. (2/7/22). "Press Release: ECBF Invests in the €16M VC Round of Elicit Plant, France, to Accelerate Commercialization of Their Water Stress Management Solutions for Field Crops Internationally". Luxembourg. 2022-02-07
Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt. 2022-02-07
AMR Action Fund. (2/7/22). "Press Release: AMR Action Fund Opens European Office". Boston, MA. 2022-02-07
Bayer AG. (2/4/22). "Press Release: Bayer Will Discontinue Phase II Development Candidate eliapixant [only for specialized press]". Berlin. 2022-02-04
Evotec SE. (2/4/22). "Press Release: Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to All P2X3 Assets [Ad hoc release]". Hamburg. 2022-02-04
iOmx Therapeutics AG. (2/3/22). "Press Release: iOmx Therapeutics Appoints Dr. Murray Yule as CMO to Lead Clinical Development". Martinsried. 2022-02-03
eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel. 2022-02-03
Nemis Technologies AG. (2/3/22). "Press Release: Nemis Technologies AG Closes a CHF 7.75 Million Series A Funding Round". Dübendorf. 2022-02-03
Bayer AG. (2/3/22). "Press Release: Bayer Appoints Christine Roth as New Head of Oncology Strategic Business Unit at Pharmaceuticals Division". Berlin. 2022-02-03
BRAIN Biotech AG. (2/2/22). "Press Release: AnalytiCon Discovery and Pharvaris Extend Their Collaboration". Potsdam. 2022-02-02
Celeris Therapeutics GmbH. (2/2/22). "Press Release: Celeris Therapeutics, the PIC Engineering Company, Announces the Appointment of Biotech Veterans to Lead Drug Discovery and Biology Efforts". 2022-02-02
Brainomix Ltd.. (2/1/22). "Press Release: Brainomix Announces New Partnership with Boehringer Ingelheim to Develop AI-powered Radiomic Software for Automated Assessment of Solid Tumor Cancer". Oxford. 2022-02-01
HH2E AG. (2/1/22). "Press Release: HH2E, New Strong Player in the German Green Energy Sector. HH2E Plans Investments of €2.7 Billion (CAPEX) in Projects in Germany". 2022-02-01
Medix Biochemica Oy. (2/1/22). "Press Release: Medix Biochemica Expands Its Molecular Diagnostics Business through the Acquisition of myPOLS Biotec". Espoo. 2022-02-01
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces Nomination of Kim Stratton as Chief Executive Officer". Cambridge, MA, Rostock & Berlin. 2022-02-01
Zetta Genomics Ltd.. (2/1/22). "Press Release (News): Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. 2022-02-01
BRAIN Biotech AG. (2/1/22). "Press Release: BRAIN Group Significantly Expands Its Food Enzyme Business with the Acquisition of Breatec B.V. and Comix Business". Zwingenberg. 2022-02-01
Temedica GmbH. (2/1/22). "Press Release: Temedica Partners with Noventi to Enhance Permea-generated Insights to Improve Patient Care". Munich. 2022-02-01
Centogene N.V.. (2/1/22). "Press Release: Centogene Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan". Cambridge, MA, Rostock & Berlin. 2022-02-01
Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel. 2022-02-01
Ethris GmbH. (2/1/22). "Press Release: Ethris Raises $26.3 Million Series B to Advance Pipeline of mRNA-based Therapeutics for Respiratory Diseases". Munich. 2022-02-01
Gandeeva Therapeutics, Inc.. (1/31/22). "Press Release: Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions". Vancouver, BC. 2022-01-31
Leo Pharma A/S. (1/31/22). "Press Release: Leo Pharma Appoints Christophe Bourdon as New CEO". Ballerup. 2022-01-31
Glooko, Inc.. (1/31/22). "Press Release: Glooko Acquires Germany-Based xbird, a Medical AI Company". Berlin & Palo Alto, CA. 2022-01-31
Ribbon Biolabs GmbH. (1/31/22). "Press Release: Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology". Vienna. 2022-01-31
Mainz Biomed N.V.. (1/28/22). "Press Release: Mainz Biomed Announces the Closing of its $25.8 Million Public Follow-on Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares". Berkeley, CA & Mainz. 2022-01-28
Mainz Biomed N.V.. (1/27/22). "Press Release: Mainz Biomed Appoints Steve Quinn as VP Business Development". Berkeley & Mainz. 2022-01-27
Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development". 2022-01-26
Cellino Biotech, Inc.. (1/25/22). "Press Release: Leaps by Bayer Leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing". Cambridge, MA & Leverkusen. 2022-01-25
Cytovation AS. (1/25/22). "Press Release: Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy". Bergen. 2022-01-25
InstaDeep. (1/25/22). "Press Release: InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems". London. 2022-01-25
genOway S.A.. (1/25/22). "Press Release: genOway Grants the Leading UK Academic Research Funder a Non-exclusive License for CRISPR/Cas9 Technology". Lyon. 2022-01-25
next pagenext page 1 2 3 4 ... 66 67 68  next pagenext page



Advertisement

Picture [iito] Fighting Customers 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px

» top